Orexin A role in mechanisms of reinforcement in the bed nucleus of stria terminalis
- Authors: Lebedev A.A.1, Shumilov E.G.1, Bychkov E.R.1, Morozov V.I.1, Shabanov P.D.1
-
Affiliations:
- Institute of Experimental Medicine
- Issue: Vol 13, No 2 (2015)
- Pages: 20-26
- Section: Articles
- URL: https://journal-vniispk.ru/RCF/article/view/987
- DOI: https://doi.org/10.17816/RCF13220-26
- ID: 987
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Andrei Andreevich Lebedev
Institute of Experimental Medicine
Email: aalebedev-iem@rambler.ru
Dr. Biol. Sci. (Pharmacology), Professor, Leading Researcher, S. V. Anichkov Dept. of Neuropharmacology
Eugeny Grigorievich Shumilov
Institute of Experimental MedicinePost-Graduate Student, S. V. Anichkov Dept. of Neuropharmacology
Eugeny Rudolfovich Bychkov
Institute of Experimental Medicine
Email: bychkov@mail.ru
PhD (Biochemistry), Senior Researcher, S. V. Anichkov Dept. of Neuropharmacology
Vitaly Ivanovich Morozov
Institute of Experimental MedicinePhD (Therapy), Post-Doc Fellow, S. V. Anichkov Dept. of Neuropharmacology
Petr Dmitriyevich Shabanov
Institute of Experimental Medicine
Email: pdshabanov@mail.ru
Doct. of Med. Sci. (Pharmacology), Professor and Head, S. V. Anichkov Dept. of Neuropharmacology
References
- Лебедев А. А., Шабанов П. Д. Сопоставление реакции самостимуляции и условного предпочтения места при введении фенамина у крыс. Журн. высш. нервн. деят. 1992; 42 (4): 692-8.
- Лебедев А. А., Любимов А. В., Шабанов П. Д. Механизмы срыва, или возобновления потребления психоактивных средств. Обзоры по клин. фармакол. и лек. терапии. 2011; 9 (4): 3-17.
- Шабанов П. Д. Психофармакология. СПб.: Н-Л, 2008. 384 с.
- Шабанов П. Д., Лебедев А. А. Угнетение самостимуляции латерального гипоталамуса опиатами и опиоидами, вводимыми в центральное ядро миндалины у крыс. Рос. физиол. журн. им. И. М. Сеченова. 2011; 97 (2): 180-8.
- Шабанов П. Д., Лебедев А. А. Участие ГАМК- и дофаминергических механизмов ядра ложа конечной полоски в подкрепляющих эффектах психотропных средств, реализуемых через латеральный гипоталамус. Рос. физиол. журн. им. И. М. Сеченова. 2011; 97 (8): 804-13.
- Шабанов П. Д., Лебедев А. А. Нейрохимические механизмы прилежащего ядра, реализующие подкрепляющие эффекты самостимуляции латерального гипоталамуса. Мед. акад. журн. 2012; 12 (2): 68-76.
- Шабанов П. Д., Лебедев А. А., Мещеров Ш. К. Дофамин и подкрепляющие системы мозга. СПб.: Лань, 2002, 208 с.
- Шабанов П. Д., Лебедев А. А., Стрельцов В. Ф. Гормональные механизмы подкрепления. СПб.: Н-Л, 2008, 278 с.
- Akanmu M. A., Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Res. 2005; 1048: 138-45.
- Aston-Jones G., Smith R. J., Sartor H. et al. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction. Brain Res. 2010; 1314: 74-90.
- Borgland S. L., Chang S. J., Bowers M. S. et al. OrexinA/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 2009; 29: 11215-25.
- Boutrel B., de Lecea L. Addiction and arousal: The hypocretin connection. Physiol. Behav. 2008; 93: 947-51.
- De Lecea L. Hypocretins and the neurobiology of sleep-wake mechanisms. Prog. Brain Res. 2012; 198: 234-48.
- Espana R. A., Oleson E. B., Locke J. L. et al. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur. J. Neurosci. 2010; 31: 336-48.
- Espana R. A., Melchior J. R., Roberts D. C., Jones S. R. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacol. 2011; 214: 415-26.
- Estabrooke I. V., McCarthy M. T., Ko E. C. et al. Fos expressionin orexin neurons varies with behavioral state. J. Neuroscience. 2011; 21: 1656-62.
- Gotter A. L., Roecker A. J., Hargreaves R. et al. Orexin receptors as therapeutic drug targets. Prog. Brain Res. 2012; 198: 48-56.
- Hutcheson D. M., Quarta D., Halbout B. et al. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expressionof cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward. Behav. Pharmacol. 2011; 22: 173-181.
- König K. P., Klippel A. A. A stereotaxic atlas of the forebrain and lower parts of the brain stem. Baltimore, 1963. 214 p.
- Koob G. F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry. 2009; 42 (Suppl. 1): S32-S41.
- Lebedev A. A., Bychkov E. R., Shabanov P. D. Orexin A receptor antagonist SB-408124 attenuates the effect of amphetamine on the brain reward system. Eur. Neuropsychopharmacol. 2013; 23 (Suppl. 2): S244.
- Mahler S. V., Smith R. J., Moorman D. E. et al. Multiple roles for orexin/hypocretin in addiction. Progr. Brain Res. 2012; 198: 76-121.
- Mieda M., Sakurai T. Overview of orexin/hypocretin system. Progr. Brain Res. 2012; 198: 234-45.
- Morgan H. J., Jiann W. Y., Brett A. G., Dayas C. V. Insights for developing pharmacological treatments for psychostimulant relapse targeting hypothalamic peptide systems. J. Addict. Res. Ther. 2012; S.4: 2-13.
- Riday T. T., Fish E. W., Robinson J. E. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Res. 2011; 1431: 53-61.
- Smith R. J., Aston-Jones G. Orexin/hypocretin 1receptor antagonist reduces heroin self-administration andcue-induced heroin seeking. Eur. J. Neurosci. 2012; 35: 798-804.
- Shabanov P. D., Lebedev A. A. Involvement of GABA and dopaminergic mechanisms of the bed nucleus of the stria terminalis in the reinforcing effects of psychotropic substances mediated via the lateral hypothalamus. Neurosci. Behav. Physiol. 2013; 43 (4): 485-91.
- Shabanov P. D., Lebedev A. A., Bychkov E. R. Influences of intrauteral ethanol on the maturation of the monoaminergic systems in the developing rat brain. Neurosci. Behav. Physiol. 2013; 43 (8): 951-6.
- Winrow C. J., Tanis K. Q., Reiss D. R. et al. Orexin receptorantagonism prevents transcriptional and behavioral plasticity resulting from stimulant exposure. Neuropharmacol. 2010; 58: 185-94.
- Wang B., You Z. B., Wise R. A. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: Independence from the local corticotropin releasing factor network. Biol. Psychiatry. 2009; 65: 857-62.
